The Center for Autism and Related Disorders (CARD), Tarzana, Calif, and Lineagen Inc, Salt Lake City, have entered a partnership whereby CARD will offer Lineagen’s FirstStepDx® genetic test to patients and their families.
CARD is a provider of early, intensive behavioral intervention for individuals with autism spectrum disorders (ASD)s.
Lineagen is a molecular diagnostics company focused on integrated genetic testing and counseling for individuals with ASDs and other disorders of childhood development. FirstStepDx is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs.
Under the terms of the agreement, FirstStepDx, integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD’s innovative Skills® program.